Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies
- 1 August 2003
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 29 (4) , 297-307
- https://doi.org/10.1016/s0305-7372(03)00003-3
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Hypoxia upregulates Bcl‐2 expression and suppresses interferon‐γ induced antiangiogenic activity in human tumor derived endothelial cellsCancer, 2002
- The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapiesThe Journal of Pathology, 2002
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- Gene transfer of antisense hypoxia inducible factor-1 α enhances the therapeutic efficacy of cancer immunotherapyGene Therapy, 2001
- p21Cip1 and p27Kip1Regulate Cell Cycle Reentry after Hypoxic Stress but Are Not Necessary for Hypoxia-Induced ArrestMolecular and Cellular Biology, 2001
- Erythropoietin stimulates proliferation of human renal carcinoma cellsKidney International, 2000
- The P-glycoprotein multidrug transporterGeneral Pharmacology: The Vascular System, 1996
- Distribution and Activity of Antineoplastic Drugs in a Tumor ModelJNCI Journal of the National Cancer Institute, 1989
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971
- On the Origin of Cancer CellsScience, 1956